RxDoctor Payments Data

Katherine Kreber, NP

Family · Mt Pleasant, SCNPI 1306350046

Payments from drug & device makers

$1,215in general payments, 2019–2025

Across 65 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$211
  • Pfizer$171
  • Novartis$115
  • Lilly USA, LLC$115
  • Exact Sciences$112
  • AbbVie$83
  • plus $409 from 12 others

What the payments were for

  • Food & beverage$1,215100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,215 in reported general payments places this provider in the 70th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$35,813
Medicare patients
124
Services billed
535

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide24$24,843
Rosuvastatin Calcium132$2,085
Losartan Potassium67$836
Albuterol Sulfate HfaAlbuterol Sulfate24$763
Atorvastatin Calcium95$707
Gabapentin25$575
Levothyroxine Sodium68$544
Omeprazole30$487
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide36$455
Escitalopram Oxalate34$428
Ezetimibe23$403
Metoprolol Succinate39$401
Oxybutynin Chloride ErOxybutynin Chloride11$318
Amlodipine Besylate82$306
Simvastatin15$250

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$115$24,84324 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,248 family providers in South Carolina.

Other family in Mt Pleasant

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →